Salivary collection participant instructions using OMNIgene ORAL OM 501 device

By Elisa Menozzi, MD, PhD, Roxana Mezabrovschi, BSc, Sara Lucas Del Pozo, MD, Jane Macnaughtan, PhD, Sofia Koletsi, MSc, Aleesa Nazeer, MSc and Nadine Loefflad, MSc
View Published Protocol

Output Details

Description
Salivary collection participant instructions using OMNIgene ORAL OM 501 device
Identifier (DOI)
10.17504/protocols.io.n92ldm8qol5b/v1
Tags
  • DNA
  • Human
  • Metagenome
  • Saliva
Team
Team Schapira
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

  • Elisa Menozzi, MD, PhD

    Key Personnel: Team Schapira, 

    University College London

  • User avatar fallback logo

    Roxana Mezabrovschi, BSc

    Key Personnel: Team Schapira, 

    University College London

  • Sara Lucas Del Pozo, MD

    Key Personnel: Team Schapira, 

    University College London

  • User avatar fallback logo

    Jane Macnaughtan, PhD

    Collaborating PI: Team Schapira, 

    University College London

  • Sofia Koletsi, MSc

    Project Manager: Team Schapira, 

    University College London

  • User avatar fallback logo

    Aleesa Nazeer, MSc

    Key Personnel: Team Schapira, 

    University College London

  • User avatar fallback logo

    Nadine Loefflad, MSc

    Key Personnel: Team Schapira, 

    University College London

Related Research

Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics

This study demonstrates that the authors’ semi-automated protocol is suitable for shotgun metagenomic analysis.

View Article

SNP Genotyping and ApoE Genotyping

Protocol outlines DNA extraction from blood, quality control, SNP, and APOE genotyping. Adapted from PRoBaND SNP Genotyping and ApoE Genotyping Protocol by Malek et al. for Parkinson's Disease study.

View Protocol

Combining biomarkers for prognostic modelling of Parkinson’s disease

Parkinson's disease progression varies among patients. Predicting progression accurately is crucial for clinical trial selection. Blood biomarkers like serum NfL, along with genetic factors (GBA, APOE) can enhance prediction beyond age and phenotype.

View Article
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.